04/02/2022
•2024Viewpoint
Visby Medical to Exhibit at the ACOG Annual Clinical and Scientific Meeting
Visby Medical will be exhibiting at the ACOG Annual Clinical and Scientific Meeting (ACSM). ACSM has long been a gathering of the leading women’s health care experts.
![building-of-glass building-of-glass](http://visbywpstaging.visbyon-site.net/wp-content/uploads/elementor/thumbs/building-of-glass-qidxev7muygjmk9qwpi2x84weasyoggfxtce8j86l4.webp)
ACOG Annual Clinical and Scientific Meeting
May 6-8, 2022
San Diego Convention Center
111 W Harbor Dr, San Diego, CA 92101
Founded in 1951, ACOG is the premier professional membership organization for obstetrician–gynecologists. The College produces practice guidelines for health care professionals and educational materials for patients, provides practice management and career support, facilitates programs and initiatives to improve women’s health, and advocates for members and patients. The Annual Clinical and Scientific Meeting (ACSM) has long been a gathering of the leading women’s health care experts. ACSM provides attendees with cutting-edge research, clinical best practices, and collaborative solutions to the challenges faced by their members. Sessions for the meeting will center around four tracks: obstetrics, gynecology, professional development, and office practice. Concise and focused sessions across a variety of topics promise to engage attendees while providing opportunities to connect. The programming for ACSM 2022 will emphasize this year’s theme: Reconnect, Recharge, Reset.
![](http://visbywpstaging.visbyon-site.net/wp-content/uploads/2024/01/black-and-white-lady.jpg)
Don’t miss our presentation at the Product Theater and stop by our booth #905 to hold our revolutionary palm-sized PCR for three critical sexual health targets — chlamydia, gonorrhea, and trichomonas.
Learn more about the Visby Medical Sexual Health Test
Read more articles & insights
CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test
The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced today that it will award biotechnology company Visby Medical of San Jose, California, up to $1.8 million
Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women
Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the FDA for its 2nd generation point of
Visby Medical Receives FDA Emergency Use Authorization for Respiratory Health Test for Use in CLIA Waived Settings
Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of
Visby Medical Expands Series E Round to Over $135 Million
Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of